DFTX +65% on Phase 3 Results
DFTX shares rise 65% on positive topline results from Phase 3 Emerge Study of DT120
Top Big Cap Positive News Movers Premarket: DFTX: +65% Positive Topline Results from Phase 3 Emerge Study of DT120 APGE: +47% AbbVie to Acquire Apogee Therapeutics ORKA: +17% Symp. off APGE Headlines UMC: +14% Form 6K Filing - To clarify news reported by Economic Daily News on June 21, 2026 FRVO: +10% Earnings MLTX: +8% Announces Week 52 Results of Sonelokimab from its Phase 3 VELA Program in Hidradenitis Suppurativa SMCI: +8% Delivers NVIDIA Vera Rubin NVL4 End-to-End DCBBS Blueprint with Native FP64 Performance for Converged HPC and AI Infrastructure SYRE: +8% Symp. off APGE Headlines MU: +4.5% PT Raised at Needham INTC: +3% Greenstone Biosciences, Inc. and Intel Corp.
Launch Strategic Collaboration to Scale Human-Centric Drug Discovery